课题基金 / 基金详情

Science Master's Program: Creation of a New Master's Program in Medical and Industrial Biotechnology

Science Master's Program: Creation of a New Master's Program in Medical and Industrial Biotechnology
科学硕士课程:创建新的医学和工业生物技术硕士课程
批准号:
1011509
负责人:
Matthew DeLisa
金额:
$70.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-15 至 2013-07-31

项目摘要

项目成果

Matthew DeLisa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5).Science Master's Program: Creation of a New Master's Program in Medical and Industrial Biotechnology (PI: DeLisa; Lead Institution: Cornell University)Biotechnology is widely recognized as one of the key enabling technologies of the 21st century with potential applications in numerous diverse industries including health and medicine (diagnosing, treating and preventing disease), agriculture (genetic engineering of plants and animals for food and fiber), energy (biofuels and bio-based products), and manufacturing (food processing and chemical engineering). From an economic development perspective, biotechnology is a desirable industry because biotechnology firms have the potential to generate high-paying, high-skill jobs. However, as a knowledge-based industry, biotechnology is largely dependent on the availability of specially trained professionals, particularly research scientists, engineers and technicians. Thus, this proposal seeks to cultivate the next generation of highly trained US graduate students who meet the growing needs of biotechnology employers and are prepared for careers in an area of significant employment growth. To accomplish this goal, a new master?s degree in Medical and Industrial Biotechnology will be created at Cornell University. This program has been specifically designed to introduce graduate trainees to the broad, interdisciplinary nature of the biotechnology industry by integrating a curriculum of modern biology, bioengineering and business courses with in-depth, hands-on biotechnology research training. This program will actively and aggressively broaden participation in science and engineering by working seamlessly with Cornell?s Diversity Programs in Engineering. With assistance from a 15-member industrial advisory board and over 40 faculty from 19 academic departments at Cornell, every effort will be made to recruit the most talented US citizens from diverse disciplines ranging from engineering to the physical and life sciences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collaborative Research: Cell-free glycoprotein synthesis technology for point-of-care vaccine biomanufacturing
  • 批准号:
    1936823
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $40.07万
  • 财政年份:
    2020
  • 负责人:
    Matthew DeLisa
  • 依托单位:
The trajectory of research at the intersection of biology and engineering
  • 批准号:
    1838611
  • 项目类别:
    Standard Grant
  • 资助金额:
    $4.95万
  • 财政年份:
    2018
  • 负责人:
    Matthew DeLisa
  • 依托单位:
A scalable pipeline for generating synthetic antibodies against designer glycotopes
  • 批准号:
    1605242
  • 项目类别:
    Standard Grant
  • 资助金额:
    $30.0万
  • 财政年份:
    2016
  • 负责人:
    Matthew DeLisa
  • 依托单位:
Collaborative Research: Glycoengineering Without Borders: Bacterial Cell-Free Glycoprotein Synthesis
  • 批准号:
    1411715
  • 项目类别:
    Standard Grant
  • 资助金额:
    $30.0万
  • 财政年份:
    2014
  • 负责人:
    Matthew DeLisa
  • 依托单位:
国内基金
海外基金
超对称可积系统:master对称、Cartan-Maurer方程
  • 批准号:
    11505284
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2015
  • 负责人:
    田凯
  • 依托单位: